BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18564619)

  • 1. [Prevention and treatment of nausea and vomiting induced by chemotherapy. Introduction].
    Schittulli F
    Tumori; 2008; 94(2):suppl 1-5. PubMed ID: 18564619
    [No Abstract]   [Full Text] [Related]  

  • 2. [ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting].
    Longo F; Mansueto G; Magnolfi E
    Tumori; 2006; 92(1):suppl 24-31. PubMed ID: 16683393
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy. An overview of nausea and vomiting in the cancer patient: etiology and management of serious complications of chemotherapy.
    Needleman R
    AAOHN J; 1987 Apr; 35(4):179-82. PubMed ID: 2950890
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of chemotherapy-induced nausea and vomiting.
    Zubairi IH
    Br J Hosp Med (Lond); 2006 Aug; 67(8):410-3. PubMed ID: 16918094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncology Patient Evidence-Based Notes (OPEN): antiemetics for chemotherapy-induced nausea and vomiting.
    Cope D
    Clin J Oncol Nurs; 2003; 7(4):461-2. PubMed ID: 12929282
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine for nausea and vomiting.
    Licup N
    Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rolapitant approved for chemotherapy-induced nausea and vomiting.
    Traynor K
    Am J Health Syst Pharm; 2015 Nov; 72(21):1838. PubMed ID: 26490812
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
    Aapro MS
    Ariz Med; 1981 Nov; 38(11):843-5. PubMed ID: 6274276
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy-induced nausea and vomiting: strategies for prevention and treatment.
    Schwartzberg LS
    Clin Adv Hematol Oncol; 2017 Dec; 15(12):906-913. PubMed ID: 29315282
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy-induced nausea and vomiting.
    Sledge GW
    Curr Opin Oncol; 1990 Oct; 2(5):909-14. PubMed ID: 2095894
    [No Abstract]   [Full Text] [Related]  

  • 12. [New aspects in the prevention and therapy of cytostatic drug-induced nausea and vomiting].
    Evers C; Riess H
    Z Arztl Fortbild (Jena); 1992 Sep; 86(17):847-53. PubMed ID: 1413901
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy-induced nausea and vomiting.
    Scogna DM; Smalley RV
    Am J Nurs; 1979 Sep; 79(9):1562-4. PubMed ID: 258563
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement.
    Einhorn LH; Grunberg SM; Rapoport B; Rittenberg C; Feyer P
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S1-4. PubMed ID: 20505956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the hospital pharmacist in the management of chemotherapy-induced nausea and vomiting].
    Breton D; Jandard V; Cauet A; Paillet M; Galvez O; Faure A; Camus G; Beltrando X; Rimlinger H; Hervouet M; Margery J; Bohand X; Vaylet F
    J Pharm Belg; 2011 Jun; (2):46-50. PubMed ID: 21823442
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Zee B; Warr D; Latreille J; Kaizer L; Pater J
    Support Care Cancer; 1997 Jul; 5(4):307-13. PubMed ID: 9257427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference.
    Roila F; Herrstedt J; Gralla RJ; Tonato M
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S63-5. PubMed ID: 21188425
    [No Abstract]   [Full Text] [Related]  

  • 18. Asking the obvious questions regarding patient burden.
    Sloan J
    J Clin Oncol; 2002 Jan; 20(1):4-6. PubMed ID: 11773146
    [No Abstract]   [Full Text] [Related]  

  • 19. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.
    Warr JK; Chambers CR; Cusano FL; Cuthbert CA; Mah MS
    J Oncol Pharm Pract; 2015 Oct; 21(5):348-57. PubMed ID: 24938292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine for cancer-related nausea and vomiting.
    LeGrand SB; Walsh D
    J Pain Symptom Manage; 2010 Jul; 40(1):136-41. PubMed ID: 20619216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.